Jonathan Young
CIK 1779805 · Chief Operating Officer · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
1
Total Filings
61
Lifetime Open-Market Net
-$13.41M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics, Inc. (AKRO) Delisted | Chief Operating Officer | 0 | $54.65 | $0 | -$13.41M | 61 | 2025-12-09 |
Recent Filings · Page 4 of 7
61 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-29 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$95.5K | EDGAR |
| 2023-12-18 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −543 | -$11.3K | EDGAR |
| 2023-12-12 | Akero Therapeutics, Inc. (AKRO) Delisted | Grant (A) | +32,497 | $0 | EDGAR |
| 2023-11-21 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −30,000 | -$440.3K | EDGAR |
| 2023-10-04 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$14.7K | EDGAR |
| 2023-09-25 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −562 | -$28.3K | EDGAR |
| 2023-06-15 | Akero Therapeutics, Inc. (AKRO) Delisted | Sell (S) | −538 | -$29.7K | EDGAR |
| 2023-03-14 | Akero Therapeutics, Inc. (AKRO) Delisted | Tax (F) | −634 | -$27.6K | EDGAR |
| 2023-01-05 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$474.2K | EDGAR |
| 2022-12-28 | Akero Therapeutics, Inc. (AKRO) Delisted | Mixed | — | -$544.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.